Adenosine provokes diastolic dysfunction in microvascular angina

D Vinereanu1, A G Fraser, M Robinson

  • 1Department of Cardiology, University Hospital of Wales, Cardiff, UK.

Insights

Adenosine stress echocardiography revealed diastolic dysfunction in patients with microvascular angina. This dysfunction, particularly long axis diastolic dysfunction, was easily detected using tissue Doppler of the lateral mitral annulus.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Diagnostic Imaging

Background:

  • Microvascular angina is characterized by chest pain despite normal coronary arteries.
  • Assessing cardiac function during stress is crucial for diagnosing and managing angina.
  • Diastolic dysfunction can be an early indicator of cardiac compromise.

Purpose of the Study:

  • To investigate the effects of adenosine stress on global and regional ventricular function in patients with microvascular angina.
  • To determine if adenosine stress induces diastolic dysfunction.
  • To evaluate the utility of tissue Doppler echocardiography in detecting stress-induced diastolic dysfunction.

Main Methods:

  • Adenosine stress echocardiography was performed in nine patients with microvascular angina.
  • Global ventricular function was assessed using Tc(99m) blood pool imaging and Doppler.
  • Longitudinal ventricular function was assessed using simultaneous tissue Doppler echocardiography of the lateral mitral annulus.

Main Results:

  • Adenosine infusion did not significantly alter global or longitudinal systolic function.
  • Adenosine induced global diastolic dysfunction, evident on blood pool imaging and transmitral flow Doppler.
  • All patients exhibited long axis diastolic dysfunction at peak adenosine, indicated by a specific mitral annular velocity ratio.

Conclusions:

  • Adenosine stress provokes regional and global diastolic dysfunction in microvascular angina.
  • Subendocardial ischemia may underlie the observed diastolic dysfunction.
  • Tissue Doppler of the lateral annular motion is a sensitive method for detecting long axis diastolic dysfunction.

Related Concept Videos

Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...